RDY

Dr. Reddy's Laboratories Ltd Common Stock

RDY · Salud · Next earnings: 23 Oct 2026 · Time not confirmed · Q3 2026

Relevance 24/100 · Minor

1-year price history

Source: Yahoo Finance
- Calculating change...

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Company

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment.

What the market expects

ConsensusPrior-year EPS
EPS0.160.19
Revenue85,959,830,740—

1 analysts

How expectations have moved

Expectations: Neutral

Expectativas neutrales: cotiza un 20% por debajo de su máximo de 52 semanas.

Stock, 90 days
-5.4%

Prior behaviour

Average absolute move
4.4%
Largest move
9.4%
releases with a move larger than 5%
50%
beat the EPS consensus in
1 of the last 4
Quarter Date 1-session move Surprise EPS
Jun 2026 22 Jul 2026 -9.4% -64.7%
Mar 2026 12 May 2026 -5.2% -33.3%
Dec 2025 21 Jan 2026 +2.6% +0.0%
Sep 2025 24 Oct 2025 -0.3% +5.6%

Historical moves describe typical magnitude, not a future direction.

Expected move

±4.4% (historical)

“±X%” is the typical move size, not a forecast of direction.

Stock situation

Price
12.48
30 days
+5.0%
90 days
-5.4%
Distance to 52-week high
-20.4%
Market cap
10,182,814,700

Metrics to watch

Relevance breakdown
market_cap
4.9
analyst_coverage
0.4
recent_price_move
2.0
historical_earnings_vol
6.6
sector_importance
4.0
recent_news_coverage
0.0

Disclaimer

Radar Acciones provides information and analysis tools, not personalised investment advice. Consensus and expectations data describe the setup around an event with objective figures; they must never be read as a forecast of direction or price.